Yamaguchi et al. observed that among ccRCC patients, the Nrf2*A allele was associated with increased protein expression, and in the metastatic setting, it corresponded with worse therapy response and unfavorable outcome [59]. Here, NFE2L2 is linked to nonpapillary renal cell carcinoma.